First-Line Medications for Acute Uncomplicated UTI
For acute uncomplicated urinary tract infection in non-pregnant, otherwise healthy adult women, use nitrofurantoin 100 mg twice daily for 5 days, fosfomycin trometamol 3 g single dose, or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days as first-line therapy, with the choice dependent on local resistance patterns. 1
First-Line Treatment Options
The 2024 European Association of Urology guidelines and 2019 AUA/CUA/SUFU guidelines establish three primary first-line agents 1:
Nitrofurantoin (Preferred in Many Settings)
- Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days 1
- Alternative dosing: 50-100 mg four times daily for 5 days 1
- Avoid if early pyelonephritis is suspected (inadequate tissue penetration) 1
- Lower risk of antimicrobial resistance compared to other agents 1
- Recent evidence suggests nitrofurantoin may have lower treatment failure rates than trimethoprim-sulfamethoxazole 2
Fosfomycin Trometamol
- 3 g single dose 1
- Recommended only for women with uncomplicated cystitis 1
- Convenient single-dose regimen improves compliance 1
- Lower efficacy than some other first-line agents; avoid if early pyelonephritis suspected 1
Trimethoprim-Sulfamethoxazole (TMP-SMX)
- 160/800 mg (one double-strength tablet) twice daily for 3 days 1, 3
- Only use if local E. coli resistance is <20% 1
- Avoid if patient used TMP-SMX for UTI in previous 3 months 1
- Increasing resistance rates limit its use in many communities 1, 2
- Not recommended in first trimester of pregnancy 1
Pivmecillinam (Where Available)
- 400 mg three times daily for 3-5 days 1
- Not available in the United States 1
- Lower efficacy than some other recommended agents 1
Second-Line/Alternative Agents
When first-line agents cannot be used due to resistance patterns, allergies, or availability 1:
Cephalosporins
- Cefadroxil 500 mg twice daily for 3 days (or comparable cephalosporin) 1
- Only if local E. coli resistance <20% 1
- Generally have inferior efficacy and more adverse effects compared to first-line agents 1
Fluoroquinolones (Use Restricted)
- Ciprofloxacin 250-500 mg twice daily for 3 days 4
- Levofloxacin 250 mg daily for 3 days 1
- Not recommended as first-line due to collateral damage and serious FDA safety warnings 1
- High resistance prevalence in many areas precludes empiric use 1, 5
- Reserve for complicated cases or when other options unavailable 1
Trimethoprim Alone
Treatment Duration Principles
Keep antibiotic courses as short as reasonable, generally no longer than 7 days 1:
- 3-5 days for most first-line agents 1
- Shorter courses reduce adverse effects and antimicrobial resistance 1
- Longer courses do not improve outcomes in uncomplicated UTI 1
Critical Pitfalls to Avoid
Do Not Use These Agents
- Amoxicillin or ampicillin should NOT be used empirically due to very high resistance rates worldwide 1
- Beta-lactams other than pivmecillinam should be used with caution due to inferior efficacy and higher adverse effects 1
When to Obtain Urine Culture
Urine culture is NOT needed for typical uncomplicated cystitis but IS required for 1:
- Suspected acute pyelonephritis
- Symptoms not resolving or recurring within 4 weeks after treatment
- Atypical symptoms
- Pregnant women
- Recurrent UTI patients (before each episode) 1
Treatment Failure Management
If symptoms do not resolve by end of treatment or recur within 2 weeks 1:
- Obtain urine culture and susceptibility testing
- Assume organism is not susceptible to original agent
- Retreat with 7-day regimen using different agent 1
Special Considerations for Men
Men with uncomplicated UTI require longer treatment duration 1:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days 1
- Fluoroquinolones can be prescribed according to local susceptibility 1
- Always obtain urine culture in men 6
- Consider urethritis and prostatitis as alternative diagnoses 6
Resistance Pattern Considerations
The choice between first-line agents must account for local resistance patterns 1:
- If TMP-SMX resistance >20% in your community, choose nitrofurantoin or fosfomycin 1
- Recent TMP-SMX exposure increases treatment failure risk 2
- Fluoroquinolone resistance is high in many areas, limiting their utility 1, 5
- Nitrofurantoin maintains low resistance rates due to lack of cross-resistance with commonly prescribed antimicrobials 7